Biotechnology
Technology
Health
BioMarin
$81.609876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$81.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.03 (0.04%) Today
$0.00 (0.00%) As of 4:27 PM EDT after-hours
Why Robinhood?
You can buy or sell BioMarin and other stocks, options, ETFs, and crypto commission-free!
About BMRN
BioMarin Pharmaceutical Inc. Common Stock, also called BioMarin, is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Read More Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.
Employees
2,849
Headquarters
San Rafael, California
Founded
1997
Market Cap
14.60B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.11M
High Today
$82.49
Low Today
$80.99
Open Price
$81.93
Volume
700.93K
52 Week High
$106.74
52 Week Low
$79.13
Collections
Biotechnology
Technology
Health
Pharmaceutical
Medical
US
North America
BMRN News
Price Paid on Robinhood
10% Lower
Right Now
52 Week Low
$79.13
Average Price Paid
$91.01
52 Week High
$106.74
Analyst Ratings
75%
of 24 ratings
Buy
75%
Hold
25%
Sell
0%
BMRN Earnings
-$0.32
-$0.20
-$0.09
$0.03
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Aug 1, After Hours